Beta Bionics (BBNX) Free Cash Flow (2024 - 2026)
Beta Bionics' Free Cash Flow history spans 3 years, with the latest figure at -$25.2 million for Q1 2026.
- On a quarterly basis, Free Cash Flow fell 24.13% to -$25.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$61.1 million, a 2.86% decrease, with the full-year FY2025 number at -$56.2 million, down 8.81% from a year prior.
- Free Cash Flow hit -$25.2 million in Q1 2026 for Beta Bionics, down from -$13.9 million in the prior quarter.
- Over the last five years, Free Cash Flow for BBNX hit a ceiling of -$8.7 million in Q3 2025 and a floor of -$25.2 million in Q1 2026.
- Historically, Free Cash Flow has averaged -$14.8 million across 3 years, with a median of -$13.4 million in 2025.
- The widest YoY moves for Free Cash Flow: up 24.58% in 2025, down 61.82% in 2025.
- Tracing BBNX's Free Cash Flow over 3 years: stood at -$14.8 million in 2024, then grew by 6.43% to -$13.9 million in 2025, then plummeted by 81.54% to -$25.2 million in 2026.
- Business Quant data shows Free Cash Flow for BBNX at -$25.2 million in Q1 2026, -$13.9 million in Q4 2025, and -$8.7 million in Q3 2025.